Evogene Market Cap

Evogene has a market cap or net worth of 29.95 million as of December 5, 2025. Its market cap has decreased by -23.83% in one year.

Market Cap

29.95M

Enterprise Value

38.80M

Revenue

26.54M

Ranking

n/a

PE Ratio

n/a

Stock Price

344.30

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 113.15M to 29.95M, a decrease of -73.53%. That is a compound annual growth rate of -7.06%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	29.95M	-36.75%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	549.28M	305.78%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	105.66B
Danel (Adir Yeoshua)	2.71B
Kamada	1.33B
BrainsWay	1.08B
Bait Bakfar	1.04B
SofWave Medical	997.78M
Ilex Medical	717.72M
Novolog (Pharm-Up 1966)	644.72M

Market Cap Rankings